Delivery Order SPE2DB20D3303-SPE2DB25FA0RR
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,097.90 firm fixed-price delivery order contract is for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent certain types of blood clots. The contract has a performance period through May 1, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,862.40 firm fixed-price delivery order is for the supply of Eliquis 2.5 mg tablets, a medication used to treat and prevent blood clots. The contract has an ultimate completion date of April 18, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,055.03 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent certain types of blood clots. The contract has an ultimate completion date of May 1, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite...
- This federal contract award is a delivery order valued at $11,984.53 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Eliquis 5 mg tablets, a prescription medication used to treat and prevent blood clots. The contract is a firm fixed-price, non-set-aside award with a performance period through May 2, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,923.34 firm-fixed-price delivery order is for the supply of Eliquis 2.5 mg tablets, a medication used to treat and prevent blood clots. The contract has an ultimate completion date of August 1, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- This federal contract award, valued at $55,833.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. This is a firm fixed-price delivery order contract with an ultimate completion date of April 17, 2025. The award is not set-aside and was competitively issued. AmerisourceBergen Drug...
- This federal contract award, valued at $47,953.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract is a Firm Fixed Price arrangement with an ultimate completion date of April 22, 2025. This award is not associated with a set-aside program and represents...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,070.42 delivery order contract is for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has a firm fixed-price pricing type and a completion date of November 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,545.80 firm-fixed-price delivery order is for Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The award has an ultimate completion date of October 21, 2024 and was made on October 18, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- This federal contract award, valued at $1,883.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. This is a firm fixed-price delivery order contract with an ultimate completion date of April 30, 2025. The award is not set-aside and represents open competition. AmerisourceBergen Drug...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA0RRDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,507.66 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a medication used to treat and prevent blood clots. The contract has an ultimate completion date of June 26, 2025 and is not a set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 6/25/25 |